Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference.
Gunay-Aygun
Meral
M
National Human Genome Research Institute, the Molecular Imaging Program, National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-1851, USA. mgaygun@mail.nih.gov
Avner
Ellis D
ED
Bacallao
Robert L
RL
Choyke
Peter L
PL
Flynn
Joseph T
JT
Germino
Gregory G
GG
Guay-Woodford
Lisa
L
Harris
Peter
P
Heller
Theo
T
Ingelfinger
Julie
J
Kaskel
Frederick
F
Kleta
Robert
R
LaRusso
Nicholas F
NF
Mohan
Parvathi
P
Pazour
Gregory J
GJ
Shneider
Benjamin L
BL
Torres
Vicente E
VE
Wilson
Patricia
P
Zak
Colleen
C
Zhou
Jing
J
Gahl
William A
WA
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001652:Bile Ducts / Q000378:metabolism; D015220:Calcium Channels / Q000378:metabolism; D002648:Child; D018450:Disease Progression; D015870:Gene Expression; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy / Q000453:epidemiology; D007686:Kidney Tubules, Distal / Q000378:metabolism; D007687:Kidney Tubules, Proximal / Q000378:metabolism; D008103:Liver Cirrhosis / Q000151:congenital* / Q000453:epidemiology / Q000628:therapy*; D010641:Phenotype; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D017354:Point Mutation / Q000235:genetics; D017044:Polycystic Kidney, Autosomal Recessive / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy*; D011956:Receptors, Cell Surface / Q000235:genetics / Q000378:metabolism
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D015220:Calcium Channels; C451750:PKHD1 protein, human; D011956:Receptors, Cell Surface; D010727:Phosphoric Diester Hydrolases